Seeing Is Believing
LPCN is currently covered by 1 analysts with an average price target of $17.02. This is a potential upside of $14.12 (486.9%) from yesterday's end of day stock price of $2.9.
Lipocine's activity chart (see below) currently has 3 price targets and 9 ratings on display. The stock rating distribution of LPCN is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 241.5 days.
Highest price target for LPCN is $8, Lowest price target is $8, average price target is $8.
Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 19-Aug-2025. First documented stock forecast 19-Dec-2016.
Currently out of the existing stock ratings of LPCN, 4 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$8
$4.98 (164.90%)
$8
2 months 5 days ago
(19-Aug-2025)
0/4 (0%)
$4.96 (163.16%)
Buy
$51
2 years 2 months 28 days ago
(27-Jul-2023)
0/1 (0%)
$26.69 (109.79%)
Buy
$51
4 years 4 months 28 days ago
(26-May-2021)
1/1 (100%)
$22.61 (79.64%)
228
Hold
$34
$30.98 (1025.83%)
$15
7 years 9 months 14 days ago
(10-Jan-2018)
2/2 (100%)
$2.21 (6.95%)
738
What is LPCN (Lipocine) average time for price targets to be met?
Which analyst has the current highest performing score on LPCN (Lipocine) with a proven track record?
Which analyst has the current lower performing score on LPCN (Lipocine) with a proven track record?
Which analyst has the most public recommendations on LPCN (Lipocine)?
Which analyst is the currently most bullish on LPCN (Lipocine)?
Which analyst is the currently most reserved on LPCN (Lipocine)?